DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Motzer RJ, Hutson TE, McCann L. et al.
Overall survival in renal-cell carcinoma with pazopanib versus sunitinib.
The New England journal of medicine 2014;
370: 1769-1770
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.